• SENSEX 73,246.03
    -352.64 (--0.48%)
  • BANKNIFTY 54,267.40
    292.50 (+0.54%)
  • Jio Platforms
    1,423.80 1,423.80(%)
  • NSE
    1,766.00 1,640.25(%)
  • Reliance Industries
    1,156.60 1,152.30(%)
  • Piramal Pharma
    235.45 235.45(%)
  • United Breweries
    1,316.00 1,845.90(%)
  • Larsen & Toubro
    3,892.00 4,440.00(%)
  • Billionbrains
    190.80 227.00(%)
  • Swiggy
    183.05 174.30(%)
  • Cholaman.Inv.&Fn
    1,557.55 1,952.00(%)
  • Syngene Intl.
    418.75 678.00(%)
  • HDFC Bank
    687.15 1,017.90(%)
  • Lenskart Solut.
    697.50 725.00(%)
  • HDFC AMC
    2,317.50 2,901.00(%)
  • Patanjali Foods
    375.20 613.95(%)
  • Ola Electric
    37.44 51.84(%)
  • One 97
    1,640.50 1,856.50(%)
  • Acutaas Chemical
    3,686.00 1,571.20(%)
  • Sahajanand Medi
    462.10 347.50(%)
  • Jubilant Ingrev.
    581.55 535.30(%)
  • FSN E-Commerce
    345.45 351.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Parmax Pharma Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 6620.0
  • ISIN : INE240T01014
135.05 -1 (-0.99%)
  • As on 28 Oct 2026 (EOD)

  • Today’s Low

    135.05

  • Today’s High

    135.05

  • Open

    135.05

  • Perv Close

    136.40

  • 52W Low

    22.60

  • 52W High

    139.10

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    92.90

  • Div & Yield %

    0.00

  • Book Value(₹)

    6.68

  • Debt-Equity Ratio

    -0.99

  • AGM Date

    26-Oct-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    92.90

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    6.88

  • BV (₹)

    6.70

  • Sales( ₹ in Cr.)

    12.11

  • NP (in Cr.)

    -4.16

  • NP Var(%)

    -307.0

  • Div%

    0.0

  • CPS (₹)

    -4.60

  • EPS (₹)

    -6.00

  • Traded Value (₹ in Lakhs)

    92.90

  • 52 Week High

    139.10

  • 52 Week Low

    22.60

  • Price BSE

    135.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    92.90

  • P/C Ratio

    -29.50

  • P/E Ratio

    -22.30

  • Price Vs.BV

    -6.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 12.11 28.20 11.05 15.42 18.25 26.20
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 12.11 28.20 11.05 15.42 18.25 26.20
Other Income 0.05 0.04 0.05 0.04 0.06 0.09
Stock Adjustments 3.18 0.66 -0.02 0.02 -0.43 0.52
Total Income 15.34 28.90 11.08 15.48 17.88 26.81
EXPENDITURE :            
Raw Materials 13.06 22.20 7.03 5.51 6.29 13.96
Power and Fuel Cost 1.45 1.84 2.30 1.98 2.31 2.09
Employee Cost 2.11 2.60 2.91 2.80 3.46 3.54
Other Manufacturing Expenses 0.75 0.35 1.03 1.53 1.66 2.13
Selling and Administration Expenses 1.54 1.62 0.67 0.87 1.03 0.95
Miscellaneous Expenses 0.02 1.08 0.47 0.50 0.52 0.63
Employee Benefit Expenses 2.11 2.60 2.91 2.80 3.46 3.54
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 18.93 29.69 14.40 13.19 15.27 23.30
Operating Profit -3.59 -0.77 -3.32 2.29 2.63 3.52
Interest 1.24 0.59 0.62 0.37 0.39 0.37
Gross Profit -4.83 -1.36 -3.94 1.92 2.24 3.15
Depreciation 1.01 1.03 1.71 1.88 1.93 1.94
Profit Before Tax -5.84 -2.39 -5.65 0.04 0.31 1.21
Current Tax 0.00 0.00 0.13 0.19 0.22 0.30
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -1.69 -0.30 -0.03 -0.04 -0.05 0.16
Reported Net Profit -4.16 -2.09 -5.75 -0.10 0.14 0.75
Extraordinary Items 0.00 -1.07 0.00 0.00 0.00 0.00
Adjusted Net Profit -4.16 -1.02 -5.75 -0.10 0.14 0.75
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -6.44 -4.35 1.40 1.51 1.37 0.61
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -10.60 -6.44 -4.35 1.40 1.51 1.37
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -9.34 -4.70 -12.92 -0.23 0.32 1.69
Earnings Per Share(Adj)-Unit Curr -9.34 -4.70 -12.92 -0.23 0.32 1.69
Book Value -13.81 -4.47 0.24 13.16 13.39 13.07
Book Value(Adj)-Unit Curr -13.81 -4.47 0.24 13.16 13.39 13.07

Shareholding Pattern

  • Promoter Group

    64.66%

  • Public Share Holding

    35.34%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 4,447,794 64.66 2,167,350 12
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,447,794 64.66 2,167,350 12
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 14,051 0.20 12,451 7
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 7,064 0.10 7,064 12
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 22,423 0.33 12,423 16
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,169,419 17.00 312,277 10
Individuals holding nominal share capital up to Rs. 1 lakh 1,218,134 17.71 282,604 2,098
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,431,092 35.34 626,820 2,144
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 6,878,886 100.00 2,794,170 2,156

Company Background

Parmax Pharma LtdPharmaceuticals - Indian - Bulk Drugs

  • Parmax Pharma Ltd
  • BSE Code : 6620.0
  • ISIN : INE240T01014

  • Incorporation Year

    1994

  • Registered Office

    Plot No 20 Survey No 52
    Tal Kotda Sangani Hadamtala, Rajkot,
    Gujarat-360311

  • Telephone

    91-2827-270534/535

  • FAX

  • Chairman

  • Managing Director

    Umang Alkesh Gosalia

  • Company Secretary

  • Auditor

    B A Shah S R Mehta & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Purva Sharegistry (I) Pvt Ltd
    9 ShivShakti Indl Es,
    J R Boricha Marg,Lower Parel
    Mumbai - Mumbai - 400 011

Parmax Pharma Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Parmax Pharma 135.05 12.16 12.11 -77.61 0.00
Abbott India 26,278.90 7,217.19 6,929.05 34.58 43.78
Astrazeneca Phar 6,234.70 2,304.07 2,275.58 91.89 27.86
Glaxosmi. Pharma 2,496.65 3,932.76 3,790.20 39.88 58.17
Novartis India 1,805.95 393.10 354.33 45.60 15.94
Cipla 1,360.00 20,102.60 18,979.95 41.45 13.88
Bliss GVS Pharma 650.05 773.53 729.81 60.41 12.51
Amrutanjan Healt 491.10 520.13 502.55 26.30 24.16
Fermenta Biotec. 443.85 474.15 450.25 20.72 18.77
Guj. Themis Bio. 355.25 168.25 165.82 94.99 18.05
Ambalal Sarabhai 35.73 19.52 3.94 66.17 6.77